Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur M Krieg

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
Nature Biotechnology|May 12, 2019
Mind the gap!Arthur M Krieg
Nature Immunology|April 21, 2010
AIMing 2 defend against intracellular pathogensArthur M Krieg
Scandinavian Journal of Infectious Diseases|November 19, 2003
CpG DNA: trigger of sepsis, mediator of protection, or both?Arthur M Krieg
Current Oncology Reports|January 31, 2004
Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotidesArthur M Krieg
Immunity|November 23, 2007
The toll of too much TLR7Arthur M Krieg
Trends in Immunology|April 4, 2002
From A to Z on CpGArthur M Krieg
Nature Medicine|July 2, 2003
CpG motifs: the active ingredient in bacterial extracts?Arthur M Krieg
Nucleic Acid Therapeutics|February 23, 2012
CpG still rocks! Update on an accidental drugArthur M Krieg
Nature Reviews. Drug Discovery|June 10, 2006
Therapeutic potential of Toll-like receptor 9 activationArthur M Krieg
Journal for Immunotherapy of Cancer|September 19, 2025
New insights into the role of IFN-α/β and TLR7/8/9 in cancer immunotherapy and systemic autoimmunityArthur M Krieg
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Nature Biotechnology|May 12, 2019
Mind the gap!Arthur M Krieg
Nature Immunology|April 21, 2010
AIMing 2 defend against intracellular pathogensArthur M Krieg
Scandinavian Journal of Infectious Diseases|November 19, 2003
CpG DNA: trigger of sepsis, mediator of protection, or both?Arthur M Krieg
Current Oncology Reports|January 31, 2004
Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotidesArthur M Krieg
Immunity|November 23, 2007
The toll of too much TLR7Arthur M Krieg
Trends in Immunology|April 4, 2002
From A to Z on CpGArthur M Krieg
Nature Medicine|July 2, 2003
CpG motifs: the active ingredient in bacterial extracts?Arthur M Krieg
Nucleic Acid Therapeutics|February 23, 2012
CpG still rocks! Update on an accidental drugArthur M Krieg
Nature Reviews. Drug Discovery|June 10, 2006
Therapeutic potential of Toll-like receptor 9 activationArthur M Krieg
Journal for Immunotherapy of Cancer|September 19, 2025
New insights into the role of IFN-α/β and TLR7/8/9 in cancer immunotherapy and systemic autoimmunityArthur M Krieg
Pageof 13